CMC Development: From Small Molecules to Gene and Cell Therapy

At 3D-PharmXchange, we believe that a well-thought-out CMC strategy is key to project success. We have extensive experience with many drug types, for different indications and administration routes. Our expertise ranges from small molecules, monoclonals, vaccines, and biotechnology-derived products to novel therapies such as oligonucleotides and advanced therapy medicinal products (ATMP) including gene and cell therapy. Our team supports all aspects of CMC development; from early to late stage. By partnering with us, you benefit from our deep CMC expertise and our ability to guide you smoothly through each stage of CMC development with a keen eye on your development goals.